newsfilter
← Latest News
ACCESS Newswire·

Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD)

MIAMI, FLORIDA / ACCESS Newswire / February 18, 2025 / Telomir Pharmaceuticals, Inc. , or Telomir, a leader in age-reversal science, today announced groundbreaking results from its recent preclinical studies